Featured CME Programs

Upcoming CME Events

  • ARHM 2022 Logo
    Atlantic Regional Hematopathology Meeting Future Directions of Hematopathology

    Advances in hematopathology, as well as in molecular and genetic information, are evolving at a rapid rate. However, it is difficult to remain current with the latest advances, let alone interpret their meaning and applicability to diagnosis and therapy. This meeting will focus on the “Future Directions of Hematopathology” with emphasis on the role of molecular pathology and new technologies in the diagnosis, prognostic stratification and treatment of challenging cases. Participants will be asked to incorporate advances in molecular and genetic information indicators/markers and test results in order to enhance interpretation of complex cases.

    Complimentary registration for all participants; includes breakfast, lunch, coffee breaks and program

    CME Registration Deadline: Wednesday, May 17, 2023

    Register

    Details

    Saturday, May 20, 2023
    8:30AM–3:00 pm EST Exhibit Hall Open

    Fox Chase Cancer Center Auditorium
    333 Cottman Avenue
    Philadelphia, PA 19111

    View Event Flyer

    View Agenda

    Submission of Abstracts

    We invite you to submit abstracts of clinical, scientific, and educational value with a focus on the role of molecular pathology and new technologies in the diagnosis, prognostic stratification and treatment of challenging cases.

    To submit an abstract for consideration, please send the following by Monday, April 3, 2023 to [email protected]:

    1. 1-page abstract, case description and diagnosis in a Word document (NO SLIDES)
    2. In the abstract, please specify the name, credential, affiliation and email of the person presenting the case if selected for oral presentation

    Notification of cases selected will be via email.

    ... Expand

Disclosure Policy

It is the policy of the Temple Health Office for Continuing Medical Education to ensure that all sponsored continuing medical education activities are independently designed and produced and include content that is valid, objective, balanced, free of commercial bias and in the best interest to the public. Temple Health policy requires everyone in a position to control the content of an educational activity to disclose all financial relationships with ineligible companies and to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Temple Health Office for Continuing Medical Education has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to the activity.